DJIA 17,827.75 0.00 0.00%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 0.00 0.00%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Best Idea For 2014: Sanofi Rights Post-FDA Approval

Biotech's 3 Most Influential CEOs

Top Motley Fool analysts weigh in on who they think are biotech's biggest power brokers.

Biogen Idec, PML Deaths, And Hemophilia Therapies

Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

Benzinga's M&A Chatter for Tuesday November 18, 2014

Why Mylan Will Continue To Soar

Will Pfizer's Dividend Be Safe?

Pfizer is facing stiff headwinds tied to patent expiration, but its dividend appears to remain rock solid.

Teva, Fedex Shares Look Fantastic, Arch Coal Headed Lower

Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for November 13, 2014

See More Articles...